Last reviewed · How we verify
High-flow medical oxygen insufflation
High-flow medical oxygen insufflation delivers oxygen at elevated flow rates to improve tissue oxygenation and support respiratory function.
High-flow medical oxygen insufflation delivers oxygen at elevated flow rates to improve tissue oxygenation and support respiratory function. Used for Acute hypoxemic respiratory failure, Severe hypoxemia requiring high-flow oxygen support.
At a glance
| Generic name | High-flow medical oxygen insufflation |
|---|---|
| Sponsor | Outcomes'10 |
| Modality | Small molecule |
| Therapeutic area | Respiratory/Critical Care |
| Phase | FDA-approved |
Mechanism of action
This is a medical gas delivery system that provides oxygen at higher flow rates than standard supplemental oxygen, increasing the fraction of inspired oxygen (FiO2) and improving arterial oxygen saturation. It is used in acute respiratory distress and hypoxemic conditions to enhance oxygen availability to tissues and reduce the work of breathing.
Approved indications
- Acute hypoxemic respiratory failure
- Severe hypoxemia requiring high-flow oxygen support
Common side effects
- Nasal irritation or drying
- Discomfort from high-flow delivery
- Oxygen toxicity (with prolonged high-concentration use)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High-flow medical oxygen insufflation CI brief — competitive landscape report
- High-flow medical oxygen insufflation updates RSS · CI watch RSS
- Outcomes'10 portfolio CI